
Sign up to save your podcasts
Or


In this week’s issue
Patients taking warfarin were more likely to experience vitreous or macular hemorrhage with progression to neovascular AMD compared to DOACs.
Several biomarkers show promise in predicting corneal involvement in infectious conjunctivitis.
Paracentral acute middle maculopathy (PAMM) was shown to independently increase the risk of future cardiovascular events.
By Lens Pod5
55 ratings
In this week’s issue
Patients taking warfarin were more likely to experience vitreous or macular hemorrhage with progression to neovascular AMD compared to DOACs.
Several biomarkers show promise in predicting corneal involvement in infectious conjunctivitis.
Paracentral acute middle maculopathy (PAMM) was shown to independently increase the risk of future cardiovascular events.